Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Transplantation
|
May 9, 2009
Mesenchymal stem cells for therapeutic purposes
Luc Sensebé, Philippe Bourin
Bio-Medical Materials and Engineering
|
December 10, 2008
Producing MSC according GMP: process and controls
Luc Sensebé, Philippe Bourin
Medecine Sciences : M/S
|
March 31, 2011
[Mesenchymal stem cells - The challenge of a good therapeutic product]
Luc Sensebé, Philippe Bourin
Human Gene Therapy
|
October 30, 2010
Good manufacturing practices production of mesenchymal stem/stromal cells
Luc Sensebé, Philippe Bourin, Karin Tarte
Stem Cells Translational Medicine
|
November 6, 2013
Concise review: growth differentiation factor 15 in pathology: a clinical role?
Jill Corre, Benjamin Hébraud, Philippe Bourin
Methods in Molecular Biology (Clifton, N.J.)
|
November 18, 2010
A first approach for the production of human adipose tissue-derived stromal cells for therapeutic use
Philippe Bourin, Julie-Anne Peyrafitte, Sandrine Fleury-Cappellesso
European Journal of Haematology
|
November 7, 2009
DKK1 correlates with response and predicts rapid relapse after autologous stem cell transplantation in multiple myeloma
Olivia Lemaire, Michel Attal, Philippe Bourin, et al.
Frontiers in Cell and Developmental Biology
|
May 23, 2022
Editorial: MSC Communication in Physiological and Pathological Settings
Philippe Bourin, Jeffrey M Gimble, Louis Casteilla, et al.
Cancer Cell International
|
May 2, 2002
Effect of 5-azacytidine and galectin-1 on growth and differentiation of the human b lymphoma cell line bl36
Florence Poirier, Philippe Bourin, Dominique Bladier, et al.
Chronobiology International
|
April 19, 2002
In-vitro circadian rhythm of murine bone marrow progenitor production
Philippe Bourin, Arnaud F Ledain, Jacques Beau, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Transplantation
|
May 9, 2009
Mesenchymal stem cells for therapeutic purposes
Luc Sensebé, Philippe Bourin
Bio-Medical Materials and Engineering
|
December 10, 2008
Producing MSC according GMP: process and controls
Luc Sensebé, Philippe Bourin
Medecine Sciences : M/S
|
March 31, 2011
[Mesenchymal stem cells - The challenge of a good therapeutic product]
Luc Sensebé, Philippe Bourin
Human Gene Therapy
|
October 30, 2010
Good manufacturing practices production of mesenchymal stem/stromal cells
Luc Sensebé, Philippe Bourin, Karin Tarte
Stem Cells Translational Medicine
|
November 6, 2013
Concise review: growth differentiation factor 15 in pathology: a clinical role?
Jill Corre, Benjamin Hébraud, Philippe Bourin
Methods in Molecular Biology (Clifton, N.J.)
|
November 18, 2010
A first approach for the production of human adipose tissue-derived stromal cells for therapeutic use
Philippe Bourin, Julie-Anne Peyrafitte, Sandrine Fleury-Cappellesso
European Journal of Haematology
|
November 7, 2009
DKK1 correlates with response and predicts rapid relapse after autologous stem cell transplantation in multiple myeloma
Olivia Lemaire, Michel Attal, Philippe Bourin, et al.
Frontiers in Cell and Developmental Biology
|
May 23, 2022
Editorial: MSC Communication in Physiological and Pathological Settings
Philippe Bourin, Jeffrey M Gimble, Louis Casteilla, et al.
Cancer Cell International
|
May 2, 2002
Effect of 5-azacytidine and galectin-1 on growth and differentiation of the human b lymphoma cell line bl36
Florence Poirier, Philippe Bourin, Dominique Bladier, et al.
Chronobiology International
|
April 19, 2002
In-vitro circadian rhythm of murine bone marrow progenitor production
Philippe Bourin, Arnaud F Ledain, Jacques Beau, et al.
Page
of 6